User profiles for Jill Brooks

Jill M. Brooks

- Verified email at bham.ac.uk - Cited by 4501

Jill Louise Brooks

- Verified email at cmail.carleton.ca - Cited by 1125

Big-data approaches lead to an increased understanding of the ecology of animal movement

…, MG Bertram, AI Bijleveld, T Brodin, JL Brooks… - Science, 2022 - science.org
Understanding animal movement is essential to elucidate how animals interact, survive,
and thrive in a changing world. Recent technological advances in data collection and …

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled …

…, P Nankivell, J Bryant, N Sharma, R Spruce, J Brooks… - The Lancet, 2019 - thelancet.com
Background The incidence of human papillomavirus (HPV)-positive oropharyngeal cancer,
a disease affecting younger patients, is rapidly increasing. Cetuximab, an epidermal growth …

The immunology of Epstein-Barr virus–induced disease

GS Taylor, HM Long, JM Brooks… - Annual review of …, 2015 - annualreviews.org
Epstein-Barr virus (EBV) is usually acquired silently early in life and carried thereafter as an
asymptomatic infection of the B lymphoid system. However, many circumstances disturb the …

Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis

…, M Taberna, C Von Buchwald, S Tous, J Brooks… - The Lancet …, 2023 - thelancet.com
Background p16 INK4a (p16) immunohistochemistry is the most widely used biomarker assay
for inferring HPV causation in oropharyngeal cancer in clinical and trial settings. However, …

Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy.

…, RJ Tierney, WA Thomas, JM Brooks… - … (Baltimore, Md.: 1950 …, 1997 - journals.aai.org
In healthy virus carriers, EBV is subject to strong CTL responses that principally target the
EBV nuclear Ag (EBNA) 3A, 3B, 3C subset of virus proteins. In vitro-reactivated CTLs of this …

Validation of venous leg ulcer guidelines in the United States and United Kingdom

M McGuckin, R Waterman, J Brooks, G Cherry… - The American journal of …, 2002 - Elsevier
Background: Venous leg ulcers account for 85% of all lower-extremity ulcers, with treatment
costs of $3 billion and loss of 2 million workdays per year. The purpose of this study was to …

CD8 T cell recognition of endogenously expressed Epstein-Barr virus nuclear antigen 1

SP Lee, JM Brooks, H Al-Jarrah, WA Thomas… - The Journal of …, 2004 - rupress.org
The Epstein-Barr virus (EBV) nuclear antigen (EBNA)1 contains a glycine-alanine repeat (GAr)
domain that appears to protect the antigen from proteasomal breakdown and, as …

Assessment of executive function in patients with mild traumatic brain injury

J Brooks, LA Fos, KW Greve… - Journal of Trauma and …, 1999 - journals.lww.com
Background The nature of functional deficit after mild traumatic brain injury (TBI) defined by
Glasgow Coma Score of 13-15 is not fully described. This study explored the sensitivity of …

CD4+ T-Cell Responses to Epstein-Barr Virus (EBV) Latent-Cycle Antigens and the Recognition of EBV-Transformed Lymphoblastoid Cell Lines

…, NH Gudgeon, AM Leen, CW Tsang, J Brooks… - Journal of …, 2005 - Am Soc Microbiol
There is considerable interest in the potential of Epstein-Barr virus (EBV) latent antigen-specific
CD4 + T cells to act as direct effectors controlling EBV-induced B lymphoproliferations. …

Inland fisheries–Invisible but integral to the UN Sustainable Development Agenda for ending poverty by 2030

…, SC Phang, TD Beard, SD Bower, JL Brooks… - Global Environmental …, 2017 - Elsevier
The United Nations’ (UN) 2030 Agenda for Sustainable Development defines the formidable
challenge of integrating historically separate economic, social, and environmental goals …